Keep water clean
Human beings can’t survive without water. Further, the safe production of medicines depends on clean drinking water. Click here to find out more.
Search
1988-2015
Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
1948-1988
Following the death of Albert Boehringer (1861-1939), his two sons and his son-in-law Julius Liebrecht took over this family company. Learn more.
COVID-19 Volunteering in Wuhan China
Boehringer Ingelheim is striving to support community residents and the Wuhan community during this epidemic. Click here to find out and learn more.
Ridgefield
Learn more about Ridgefield, the home of Boehringer Ingelheim's US headquarters. The site serves as a key research centre for human pharmaceuticals.
weBuy
weBuy is a key initiative in order to have an integrated solution for the Source to Procure Process around the globe. Click here to find out more.
CDSCO approves SPEVIGO® (spesolimab) - the first treatment option for generalized pustular psoriasis flares in adults
CDSCO approves SPEVIGO® (spesolimab)
COVID-19 USA Double the Impact in the Fight Against COVID-19
Employees can double their impact through the BI Cares Matching Gifts Program. Click here to learn and find out more information about this.
COVID-19 Collaboration with Cantaro Azul in Mexico
Boehringer Ingelheim Mexico is collaborating with the NGO Cántaro Azul to provide hand sanitisers to people without access to clean water. Learn more here.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”. Find out more here.
COVID-Relief-India-2021
Boehringer Ingelheim prioritises life continuity to the underserved, in addition to medical aid. Click here to find out and learn more information.
COVID-19 General Q&A
Here we provide a list of questions and answers about COVID-19, including what it is, how it spreads, and more. Click here to find out more.
We create Value through Innovation for our customers
We create value through innovation for our customers. Discover how we live our Leitbild. Click here to find out more and to access related articles.
COVID-19 Boehringer Ingelheim Thailand equips frontline
Boehringer Ingelheim Thailand is working together with the Thai Department of Disease Control during the pandemic. Click here to learn more.
MORE GREEN: Environmental sustainability at a glance
On Earth Day, we share the progress of our global environmental sustainability MORE GREEN program and what the team is tackling, all 365 days of the year.
Saving Stroke Patients around the world
Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. Click here to learn about the Angels Initiative.
About Chronic Kidney Disease
Find out more about chronic kidney disease, it’s causes and symptoms
Afrika Kommt! - The Ripple Effect
What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim
COVID-19 Q&A for people with chronic respiratory conditions
Here you can find a summary of COVID-19 advice for those with chronic respiratory conditions. Click here to read the questions and answers and learn more.
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
Supporting Fundappas
Fundappas is the first school of guide and assistance dogs in Uruguay. We support Fundappas to improve the quality of life of dogs and people. Learn more.
Our Purpose
Find out what 'transforming lives' and 'for generations' means for our work and long-term thinking here. Click here to learn more about our purpose.
How pets made the pandemic bearable?
Lockdown wasn’t easy but having us work from home was certainly delightful for our pets. Learn some insights from the APPA COVID-19 Pulse Study.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.